Lista kandydacka substancji stanowiących bardzo duże zagrożenie, oczekujących na pozwolenie
Lista kandydacka substancji stanowiących bardzo duże zagrożenie, oczekujących na pozwolenie
(opublikowane zgodnie z art. 59 ust. 10 rozporządzenia REACH)
Lista kandydacka substancji stanowiących bardzo duże zagrożenie, oczekujących na pozwolenie
Uwagi:
- Wersja autentyczna: Za autentyczną uznaje się jedynie listę kandydacką opublikowaną na tej stronie. Włączenie substancji na listę kandydacką na tej stronie może nakładać na przedsiębiorstwa bezpośrednie zobowiązania prawne, wynikające zwłaszcza z art. 7, 31 i 33 rozporządzenia REACH.
- Identyfikatory numeryczne: Każdy wpis na listę kandydacką obejmuje zarówno bezwodną, jak i uwodnioną postać substancji. Numer CAS wyświetlany we wpisie jest zwykle dla postaci bezwodnej. Postaci uwodnione substancji określone innymi numerami CAS również podlegają pod ten wpis.
- Inne identyfikatory numeryczne: Tam, gdzie to możliwe, dla wpisów z „-" w kolumnach dotyczących numeru WE i numeru CAS podano niewyczerpujący wykaz numerów WE lub CAS charakteryzujących substancje lub grupy substancji, które uznaje się za wchodzące w zakres wpisu na listę kandydacką. Informacje te można uzyskać, klikając przycisk „Details" dla wybranego wpisu.
Filter the list
The List does not contain any Substances.
Pokazuje 1 - 200 z 240 wyników.
Decyzja | Zestaw danych IUCLID | ||||||
---|---|---|---|---|---|---|---|
show/hide
(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one
Nr WE:
253-242-6
| Nr CAS:
36861-47-9
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nr WE:
-
| Nr CAS:
1782069-81-1
(1R,3E,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nr WE:
-
| Nr CAS:
95342-41-9
(1S,3E,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nr WE:
-
| Nr CAS:
852541-30-1
(1R,3Z,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nr WE:
-
| Nr CAS:
852541-21-0
(1R,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nr WE:
-
| Nr CAS:
741687-98-9
(1S,3Z,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nr WE:
-
| Nr CAS:
852541-25-4
|
-
|
-
|
17-sty-2022
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
203-794-9
|
110-71-4
|
18-cze-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
253-692-3
|
37853-59-1
|
17-sty-2023
|
vPvB (Article 57e) |
Details | |||
202-486-1
|
96-18-4
|
20-cze-2011
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
Nr WE:
272-013-1
| Nr CAS:
68648-93-1
|
-
|
-
|
15-cze-2015
|
Toxic for reproduction (Article 57c) |
Details | ||
276-158-1
|
71888-89-6
|
20-cze-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
271-084-6
|
68515-42-4
|
20-cze-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
271-093-5
|
68515-50-4
|
16-cze-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
284-032-2
|
84777-06-0
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-977-3
|
112-49-2
|
18-cze-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-458-1
|
107-06-2
|
19-gru-2011
|
Carcinogenic (Article 57a) |
Details | |||
211-076-1
|
629-14-1
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
219-514-3
|
2451-62-9
|
18-cze-2012
|
Mutagenic (Article 57b) |
Details | |||
-
|
423-400-0
|
59653-74-6
|
18-cze-2012
|
Mutagenic (Article 57b) |
Details | ||
214-317-9
|
1120-71-4
|
17-gru-2015
|
Carcinogenic (Article 57a) |
Details | |||
204-661-8
|
123-91-1
|
08-lip-2021
|
Carcinogenic (Article 57a) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
Nr WE:
-
| Nr CAS:
135821-03-3
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
Nr WE:
-
| Nr CAS:
135821-74-8
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
Nr WE:
236-948-9
| Nr CAS:
13560-89-9
|
-
|
-
|
15-sty-2018
|
vPvB (Article 57e) |
Details | ||
3-benzylidene camphor; 3-BC
|
239-139-9
|
15087-24-8
|
15-sty-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
203-445-0
|
106-94-5
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
212-828-1
|
872-50-4
|
20-cze-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
214-012-0
|
1072-63-5
|
25-cze-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
201-236-9
|
79-94-7
|
17-sty-2023
|
Carcinogenic (Article 57a) |
Details | |||
202-918-9
|
101-14-4
|
19-gru-2011
|
Carcinogenic (Article 57a) |
Details | |||
AP-5
|
401-720-1
|
6807-17-6
|
15-sty-2019
|
Toxic for reproduction (Article 57c) |
Details | ||
show/hide
|
-
|
-
|
08-lip-2021
|
Carcinogenic (Article 57a) |
Details | ||
covering any of their individual isomers and combinations thereof
show/hide
potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate
Nr WE:
266-578-3
| Nr CAS:
67118-55-2
|
-
|
-
|
16-lip-2019
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
211-989-5
|
732-26-3
|
23-sty-2024
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
223-383-8
|
3864-99-1
|
17-gru-2015
|
vPvB (Article 57e) |
Details | |||
204-450-0
|
121-14-2
|
13-sty-2010
|
Carcinogenic (Article 57a) |
Details | |||
247-384-8
|
25973-55-1
|
17-gru-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
221-573-5
|
3147-75-9
|
23-sty-2024
|
vPvB (Article 57e) |
Details | |||
253-037-1
|
36437-37-3
|
17-gru-2015
|
vPvB (Article 57e) |
Details | |||
show/hide
|
-
|
-
|
08-lip-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
438-340-0
|
119344-86-4
|
23-sty-2024
|
Toxic for reproduction (Article 57c) |
Details | |||
223-346-6
|
3846-71-7
|
17-gru-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
CG 25-369; IRGACURE 369; TK 11-319
|
404-360-3
|
119313-12-1
|
16-sty-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
203-804-1
|
110-80-5
|
15-gru-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
203-839-2
|
111-15-9
|
20-cze-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
239-622-4
|
15571-58-1
|
17-gru-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
201-963-1
|
90-04-0
|
19-gru-2011
|
Carcinogenic (Article 57a) |
Details | |||
203-713-7
|
109-86-4
|
15-gru-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
203-772-9
|
110-49-6
|
16-lip-2019
|
Toxic for reproduction (Article 57c) |
Details | |||
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
|
400-600-6
|
71868-10-5
|
16-sty-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
211-765-7
|
693-98-1
|
25-cze-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
ZOLDINE MS-PLUS
|
421-150-7
|
143860-04-2
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
202-974-4
|
101-77-9
|
28-paź-2008
|
Carcinogenic (Article 57a) |
Details | |||
201-025-1
|
77-40-7
|
08-lip-2021
|
Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
209-218-2
|
561-41-1
|
18-cze-2012
|
Carcinogenic (Article 57a) |
Details | ||
202-027-5
|
90-94-8
|
18-cze-2012
|
Carcinogenic (Article 57a) |
Details | |||
Bisphenol A; BPA
|
201-245-8
|
80-05-7
|
12-sty-2017
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
212-658-8
|
838-88-0
|
19-gru-2012
|
Carcinogenic (Article 57a) |
Details | |||
show/hide
|
-
|
-
|
19-gru-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | ||
201-250-5
|
80-09-1
|
17-sty-2023
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
205-426-2
|
140-66-9
|
19-gru-2011
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
covering well-defined substances and UVCB substances, polymers and homologues
show/hide
Poly(oxy-1,2-ethanediyl), α-[(1,1,3,3-tetramethylbutyl)phenyl]-ω-hydroxy-
Nr WE:
-
| Nr CAS:
9036-19-5
20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol
Nr WE:
219-682-8
| Nr CAS:
2497-59-8
|
-
|
-
|
19-gru-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
200-453-6
|
60-09-3
|
19-gru-2012
|
Carcinogenic (Article 57a) |
Details | |||
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
12-sty-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
202-453-1
|
95-80-7
|
19-gru-2012
|
Carcinogenic (Article 57a) |
Details | |||
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
19-gru-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof
show/hide
44-(nonylphenoxy)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontanol
Nr WE:
260-678-0
| Nr CAS:
57321-10-5
4-Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
Nr WE:
500-315-8
| Nr CAS:
127087-87-0
3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-, branched
Nr WE:
293-926-1
| Nr CAS:
91648-64-5
|
799-990-1
|
-
|
20-cze-2013
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
202-679-0
|
98-54-4
|
16-lip-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nr WE:
-
| Nr CAS:
676367-06-9
Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
Nr WE:
413-720-9
| Nr CAS:
-
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
Nr WE:
-
| Nr CAS:
117933-89-8
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
Nr WE:
-
| Nr CAS:
186309-28-4
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nr WE:
-
| Nr CAS:
676367-05-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-
Nr WE:
-
| Nr CAS:
343934-04-3
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nr WE:
-
| Nr CAS:
676367-09-2
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-
Nr WE:
-
| Nr CAS:
343934-05-4
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nr WE:
-
| Nr CAS:
676367-04-7
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nr WE:
-
| Nr CAS:
676367-08-1
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nr WE:
-
| Nr CAS:
676367-03-6
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nr WE:
-
| Nr CAS:
676367-07-0
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nr WE:
-
| Nr CAS:
676367-02-5
|
-
|
-
|
15-cze-2015
|
vPvB (Article 57e) |
Details | ||
201-329-4
|
81-15-2
|
28-paź-2008
|
vPvB (Article 57e) |
Details | |||
204-327-1
|
119-47-1
|
17-sty-2022
|
Toxic for reproduction (Article 57c) |
Details | |||
204-419-1
|
120-71-8
|
19-gru-2012
|
Carcinogenic (Article 57a) |
Details | |||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
208-953-6
|
548-62-9
|
18-cze-2012
|
Carcinogenic (Article 57a) |
Details | ||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
219-943-6
|
2580-56-5
|
18-cze-2012
|
Carcinogenic (Article 57a) |
Details | ||
273-688-5
|
69011-06-9
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
257-175-3
|
51404-69-4
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
15-gru-2010
|
Carcinogenic (Article 57a) |
Details | ||
201-173-7
|
79-06-1
|
30-mar-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
287-476-5
|
85535-84-8
|
28-paź-2008
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium and silicon are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm) c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
-
|
-
|
19-gru-2011
|
Carcinogenic (Article 57a) |
Details | ||
232-143-1
|
7789-09-5
|
18-cze-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
223-320-4
|
3825-26-1
|
20-cze-2013
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
204-371-1
|
120-12-7
|
28-paź-2008
|
PBT (Article 57d) |
Details | |||
-
|
292-602-7
|
90640-80-5
|
13-sty-2010
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
292-603-2
|
90640-81-6
|
13-sty-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
295-275-9
|
91995-15-2
|
13-sty-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
295-278-5
|
91995-17-4
|
13-sty-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
292-604-8
|
90640-82-7
|
13-sty-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
231-901-9
|
7778-39-4
|
19-gru-2011
|
Carcinogenic (Article 57a) |
Details | |||
237-222-4
|
13701-59-2
|
17-sty-2023
|
Toxic for reproduction (Article 57c) |
Details | |||
200-280-6
|
56-55-3
|
15-sty-2018
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
trimellitic anhydride; TMA
|
209-008-0
|
552-30-7
|
27-cze-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
200-028-5
|
50-32-8
|
20-cze-2016
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
205-883-8
|
191-24-2
|
27-cze-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
205-916-6
|
207-08-9
|
15-sty-2019
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
201-622-7
|
85-68-7
|
28-paź-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
202-177-1
|
92-67-1
|
19-gru-2012
|
Carcinogenic (Article 57a) |
Details | |||
204-211-0
|
117-81-7
|
28-paź-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
205-594-7
|
143-24-8
|
19-sty-2021
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
17-sty-2023
|
vPvB (Article 57e) |
Details | ||
203-924-4
|
111-96-6
|
19-gru-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
204-212-6
|
117-82-8
|
19-gru-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
201-247-9
|
80-07-9
|
14-cze-2023
|
vPvB (Article 57e) |
Details | |||
214-604-9
|
1163-19-5
|
19-gru-2012
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
200-268-0
|
56-35-9
|
28-paź-2008
|
PBT (Article 57d) |
Details | |||
EC No. 233-139-2 and EC No. 234-343-4
show/hide
|
-
|
-
|
18-cze-2010
|
Toxic for reproduction (Article 57c) |
Details | ||
223-445-4
|
3896-11-5
|
23-sty-2024
|
vPvB (Article 57e) |
Details | |||
202-318-7
|
94-26-8
|
25-cze-2020
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
231-152-8
|
7440-43-9
|
20-cze-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
208-168-9
|
513-78-0
|
15-sty-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
show/hide
|
233-296-7
|
10108-64-2
|
16-cze-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
232-222-0
|
7790-79-6
|
17-gru-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
244-168-5
|
21041-95-2
|
15-sty-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
233-710-6
|
10325-94-7
|
15-sty-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
show/hide
|
215-146-2
|
1306-19-0
|
20-cze-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
show/hide
|
233-331-6
|
10124-36-4, 31119-53-6
|
17-gru-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
215-147-8
|
1306-23-6
|
16-gru-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
231-904-5
|
7778-44-1
|
19-gru-2011
|
Carcinogenic (Article 57a) |
Details | |||
215-607-8
|
1333-82-0
|
15-gru-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
205-923-4
|
218-01-9
|
15-sty-2018
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
231-589-4
|
7646-79-9
|
28-paź-2008
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
208-169-4
|
513-79-1
|
15-gru-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
200-755-8
|
71-48-7
|
15-gru-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
233-402-1
|
10141-05-6
|
15-gru-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
233-334-2
|
10124-43-3
|
15-gru-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
all possible combinations of the cis- and trans-isomers
show/hide
|
-
|
-
|
19-gru-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
D5
|
208-764-9
|
541-02-6
|
27-cze-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
215-116-9
|
1303-28-2
|
28-paź-2008
|
Carcinogenic (Article 57a) |
Details | |||
215-481-4
|
1327-53-3
|
28-paź-2008
|
Carcinogenic (Article 57a) |
Details | |||
204-650-8
|
123-77-3
|
19-gru-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | |||
215-125-8
|
1303-86-2
|
18-cze-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
201-557-4
|
84-74-2
|
28-paź-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
245-152-0
|
22673-19-4
|
25-cze-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
211-670-0
|
683-18-1
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
246-356-2
|
24613-89-6
|
19-gru-2011
|
Carcinogenic (Article 57a) |
Details | |||
DCHP
|
201-545-9
|
84-61-7
|
27-cze-2018
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
200-589-6
|
64-67-5
|
19-gru-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
201-559-5
|
84-75-3
|
16-gru-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
201-553-2
|
84-69-5
|
13-sty-2010
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
276-090-2
|
71850-09-4
|
16-sty-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
210-088-4
|
605-50-5
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
201-058-1
|
77-78-1
|
19-gru-2012
|
Carcinogenic (Article 57a) |
Details | |||
201-861-7
|
88-85-7
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
19-sty-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
235-702-8
|
12578-12-0
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
205-017-9
|
131-18-0
|
20-cze-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
278-355-8
|
75980-60-8
|
14-cze-2023
|
Toxic for reproduction (Article 57c) |
Details | |||
209-358-4
|
573-58-0
|
16-gru-2013
|
Carcinogenic (Article 57a) |
Details | |||
217-710-3
|
1937-37-7
|
16-gru-2013
|
Carcinogenic (Article 57a) |
Details | |||
234-541-0
|
12008-41-2
|
27-cze-2018
|
Toxic for reproduction (Article 57c) |
Details | |||
215-540-4
|
12179-04-3, 1303-96-4, 1330-43-4
|
18-cze-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
D6
|
208-762-8
|
540-97-6
|
27-cze-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
EDA
|
203-468-6
|
107-15-3
|
27-cze-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
292-966-7
|
91031-62-8
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
205-912-4
|
206-44-0
|
15-sty-2019
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
500-036-1
|
25214-70-4
|
19-gru-2011
|
Carcinogenic (Article 57a) |
Details | |||
200-842-0
|
75-12-7
|
18-cze-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-727-3
|
110-00-9
|
19-gru-2012
|
Carcinogenic (Article 57a) |
Details | |||
203-856-5
|
111-30-8
|
08-lip-2021
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | |||
218-165-4
|
2058-94-8
|
19-gru-2012
|
vPvB (Article 57e) |
Details | |||
206-803-4
|
376-06-7
|
19-gru-2012
|
vPvB (Article 57e) |
Details | |||
and all major diastereoisomers identified
show/hide
|
-
|
-
|
28-paź-2008
|
PBT (Article 57d) |
Details | ||
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
show/hide
|
-
|
-
|
19-gru-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
206-114-9
|
302-01-2, 7803-57-8
|
20-cze-2011
|
Carcinogenic (Article 57a) |
Details | |||
202-506-9
|
96-45-7
|
16-gru-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
224-208-8
|
4247-02-3
|
17-sty-2023
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
231-100-4
|
7439-92-1
|
27-cze-2018
|
Toxic for reproduction (Article 57c) |
Details | |||
237-486-0
|
13814-96-5
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
231-846-0
|
7758-97-6
|
13-sty-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
-
|
235-759-9
|
12656-85-8
|
13-sty-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | ||
244-073-9
|
20837-86-9
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
206-104-4
|
301-04-2
|
16-gru-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
236-542-1
|
13424-46-9
|
19-gru-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
233-245-9
|
10099-74-8
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
229-335-2
|
6477-64-1
|
19-gru-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
232-064-2
|
7784-40-9
|
28-paź-2008
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
215-267-0
|
1317-36-8
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
234-853-7
|
12036-76-9
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
239-290-0
|
15245-44-0
|
19-gru-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
215-693-7
|
1344-37-2
|
13-sty-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | ||
235-038-9
|
12060-00-3
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-727-4
|
12626-81-2
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
401-750-5
|
17570-76-2
|
18-cze-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
UVCB substances consisting of more than or equal to 80% linear chloroalkanes with carbon chain lengths within the range from C14 to C17
show/hide
|
-
|
-
|
08-lip-2021
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
203-615-4
|
108-78-1
|
17-sty-2023
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
210-894-6
|
625-45-6
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
200-879-2
|
75-56-9
|
19-gru-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
202-959-2
|
101-61-1
|
18-cze-2012
|
Carcinogenic (Article 57a) |
Details | |||
204-826-4
|
127-19-5
|
19-gru-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
200-679-5
|
68-12-2
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
213-103-2
|
924-42-5
|
10-cze-2022
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
201-182-6
|
79-16-3
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
776297-69-9
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
202-716-0
|
98-95-3
|
17-gru-2015
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
12-sty-2017
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | ||
202-591-2
|
97-56-3
|
19-gru-2012
|
Carcinogenic (Article 57a) |
Details | |||
202-429-0
|
95-53-4
|
19-gru-2012
|
Carcinogenic (Article 57a) |
Details | |||
D4
|
209-136-7
|
556-67-2
|
27-cze-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
show/hide
|
700-960-7
|
-
|
23-sty-2024
|
vPvB (Article 57e) |
Details | ||
215-235-6
|
1314-41-6
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
08-lip-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
201-280-9
|
80-46-6
|
12-sty-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
276-745-2
|
72629-94-8
|
19-gru-2012
|
vPvB (Article 57e) |
Details | |||
206-397-9
|
335-67-1
|
20-cze-2013
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
235-067-7
|
12065-90-6
|
19-gru-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
256-418-0
|
49663-84-5
|
19-gru-2011
|
Carcinogenic (Article 57a) |
Details | |||
show/hide
1-(4-butoxy-1-naphthalenyl)tetrahydrothiophenium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonate
Nr WE:
468-770-4
| Nr CAS:
-
N,N,N-triethylethanaminium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
Nr WE:
-
| Nr CAS:
25628-08-4
|
-
|
-
|
16-sty-2020
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
Pokazuje 1 - 200 z 240 wyników.